Future-Ready ADCs – Advanced Vial Solutions for Superior Stability and Performance

Antibody-drug conjugates (ADCs) promise targeted, high-potency cancer treatment, but their complexity introduces significant challenges for ADC packaging, which must ensure product stability, safety, and efficacy throughout the drug’s lifecycle. Whether it’s …

… fogging of the lyophilized drug vials that threatens container closure integrity

… light sensitivity that accelerates degradation

… or the instability of liquid formulations that risks safety and efficacy

… each step in process must rise to meet ADC’s packaging challenges.

In this talk, Diana Löber will introduce advanced vial solutions of the EVERIC® family that are designed to address these most critical needs.